This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read TransMedics Group’s 8K filing here.
About TransMedics Group
TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Featured Articles
- Five stocks we like better than TransMedics Group
- Investing In Automotive Stocks
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Technology Stocks Explained: Here’s What to Know About Tech
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- What is the S&P 500 and How It is Distinct from Other Indexes
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
